These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33795693)

  • 1. Improving estimation of Parkinson's disease risk-the enhanced PREDICT-PD algorithm.
    Bestwick JP; Auger SD; Simonet C; Rees RN; Rack D; Jitlal M; Giovannoni G; Lees AJ; Cuzick J; Schrag AE; Noyce AJ
    NPJ Parkinsons Dis; 2021 Apr; 7(1):33. PubMed ID: 33795693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different risk scores for Parkinson disease in a population-based 10-year study.
    Marini K; Seppi K; Kiechl S; Stockner H; Willeit P; Willeit J; Djamshidian A; Rungger G; Poewe W; Mahlknecht P
    Eur J Neurol; 2023 Oct; 30(10):3347-3352. PubMed ID: 37422903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease.
    Noyce AJ; R'Bibo L; Peress L; Bestwick JP; Adams-Carr KL; Mencacci NE; Hawkes CH; Masters JM; Wood N; Hardy J; Giovannoni G; Lees AJ; Schrag A
    Mov Disord; 2017 Feb; 32(2):219-226. PubMed ID: 28090684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodromal features for Parkinson's disease--baseline data from the TREND study.
    Gaenslen A; Wurster I; Brockmann K; Huber H; Godau J; Faust B; Lerche S; Eschweiler GW; Maetzler W; Berg D
    Eur J Neurol; 2014 May; 21(5):766-72. PubMed ID: 24612314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort.
    Fereshtehnejad SM; Montplaisir JY; Pelletier A; Gagnon JF; Berg D; Postuma RB
    Mov Disord; 2017 Jun; 32(6):865-873. PubMed ID: 28429825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
    Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
    Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls.
    Eisensehr I; Linke R; Tatsch K; Kharraz B; Gildehaus JF; Wetter CT; Trenkwalder C; Schwarz J; Noachtar S
    Sleep; 2003 Aug; 26(5):507-12. PubMed ID: 12938802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts.
    Pilotto A; Heinzel S; Suenkel U; Lerche S; Brockmann K; Roeben B; Schaeffer E; Wurster I; Yilmaz R; Liepelt-Scarfone I; von Thaler AK; Metzger FG; Eschweiler GW; Postuma RB; Maetzler W; Berg D
    Mov Disord; 2017 Jul; 32(7):1025-1034. PubMed ID: 28509336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.
    Noyce AJ; Dickson J; Rees RN; Bestwick JP; Isaias IU; Politis M; Giovannoni G; Warner TT; Lees AJ; Schrag A
    Mov Disord; 2018 Mar; 33(3):478-482. PubMed ID: 29380907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for prodromal Parkinson's disease in the general community: a sleep-based approach.
    Postuma RB; Pelletier A; Berg D; Gagnon JF; Escudier F; Montplaisir J
    Sleep Med; 2016 May; 21():101-5. PubMed ID: 27448479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Imaging Markers of Prodromal Parkinson's Disease.
    Hustad E; Aasly JO
    Front Neurol; 2020; 11():395. PubMed ID: 32457695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal change in dopamine transporter availability in idiopathic REM sleep behavior disorder.
    Shin JH; Lee JY; Kim YK; Shin SA; Kim H; Nam H; Jeon B
    Neurology; 2020 Dec; 95(23):e3081-e3092. PubMed ID: 32989104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prodromal PD: A new nosological entity.
    Schaeffer E; Postuma RB; Berg D
    Prog Brain Res; 2020; 252():331-356. PubMed ID: 32247370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tract-Based Spatial Statistics Reveal Lower White Matter Integrity Specific to Idiopathic Rapid Eye Movement Sleep Behavior Disorder as a Proxy for Prodromal Parkinson's Disease.
    Ohlhauser L; Smart CM; Gawryluk JR
    J Parkinsons Dis; 2019; 9(4):723-731. PubMed ID: 31498130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson's disease.
    Kang SH; Lee HM; Seo WK; Kim JH; Koh SB
    J Neurol Sci; 2016 Sep; 368():374-8. PubMed ID: 27538667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimising classification of Parkinson's disease based on motor, olfactory, neuropsychiatric and sleep features.
    Bestwick JP; Auger SD; Schrag AE; Grosset DG; Kanavou S; Giovannoni G; Lees AJ; Cuzick J; Noyce AJ
    NPJ Parkinsons Dis; 2021 Sep; 7(1):87. PubMed ID: 34561458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodromal Parkinson's disease--using REM sleep behavior disorder as a window.
    Postuma RB
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S1-4. PubMed ID: 24262156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.
    Iranzo A; Tolosa E; Gelpi E; Molinuevo JL; Valldeoriola F; Serradell M; Sanchez-Valle R; Vilaseca I; Lomeña F; Vilas D; Lladó A; Gaig C; Santamaria J
    Lancet Neurol; 2013 May; 12(5):443-53. PubMed ID: 23562390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.